ライフサイエンスコーパス: dosage regimen

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 (ie, PK) can be influenced by adjusting the dosage regimen.

2 um drug concentrations reported for standard dosage regimens.

3 fewer bleeding complications than do higher dosage regimens.

4 e of subcutaneous veltuzumab, using the same dosage regimen, again induced complete remission off the

5 and glomerular endothelial cells across all dosage regimens, and clearance of podocyte inclusions is

6 This includes the choice of agents, dosage regimens, and monitoring for response and toxicit

7 We assessed how vaccine dosage, regimen, and route of administration affected du

8 crobial drug development and optimization of dosage regimens, but systematic simulation-estimation st

9 of whole brain mitosis, suggesting that the dosage regimen did not elicit a cytotoxic, wound-healing

10 A trend toward refining dosage regimens in order to minimize the total dose of d

11 dence as to whether growth hormone in modern dosage regimens is associated with an increased risk of

12 Pretreatment of rats with an escalating dosage regimen of DF (0.5-4 mg/kg, i.p.) was associated

13 t were randomized to placebo or one of three dosage regimens of AS-013.

14 between these studies result from different dosage regimens of NaCl.

15 to mimic four different clinically relevant dosage regimens of polymyxin B and colistin over 96 h.

16 Polymyxin resistance was observed across all dosage regimens; partial reversion to susceptibility was

17 dministration at 4 testing sessions, using a dosage regimen shown to induce sensitization (ie, 3 dose

18 An intensified focus on dosage regimens targeted at bacterial killing of both th

19 postnatal days (PN) 30 through 47.5, using a dosage regimen that maintains plasma levels similar to t

20 udy may used to design an initial ranitidine dosage regimen that targets a gastric pH > or =4.

21 Polymyxin B dosage regimens that achieved peak concentrations above

22 l susceptible individuals and development of dosage regimens that maintain effective antimicrobial dr

23 with a major objective being to derive drug dosage regimens that optimize efficacy and minimize toxi

24 to use this model to optimize antimicrobial dosage regimens to minimize resistance development.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。